[{"Assets_0_FY_USD":4273012000.0,"EarningsPerShareBasic_4_FY_USD":4.12,"EarningsPerShareBasic_1_FY_USD":2.78,"EarningsPerShareDiluted_4_FY_USD":4.07,"EarningsPerShareDiluted_1_FY_USD":2.75,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":103885000.0,"NetIncomeLossConverted_4_FY_USD":122249000.0,"NetIncomeLossConverted_1_FY_USD":82700000.0,"RevenuesConverted_1_FY_USD":621300000.0,"RevenuesConverted_4_FY_USD":2160153000.0,"StockholdersEquity_0_FY_USD":2930250000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":30034000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":29655000.0,"Ticker":"BIO_2","CIK":"12208","name":"BIO RAD LABORATORIES INC","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20180416"}]